本页面由Tiger Trade Technology Pte. Ltd.提供服务

Phibro Animal Health Corporation

37.12
-0.6016-1.59%
成交量:4.60万
成交额:170.84万
市值:15.05亿
市盈率:15.28
高:37.53
开:37.53
低:36.72
收:37.72
52周最高:60.08
52周最低:28.25
股本:4,053.36万
流通股本:2,086.24万
量比:0.57
换手率:0.22%
股息:0.48
股息率:1.29%
每股收益(TTM):2.43
每股收益(LYR):2.43
净资产收益率:29.72%
总资产收益率:8.48%
市净率:3.90
市盈率(LYR):15.28

数据加载中...

2026/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/27

重要事件披露

Form 8-K - Current report
2026/08/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/08/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/29

重要事件披露

Form 8-K - Current report
2026/06/26

重要事件披露

Form 8-K - Current report
2026/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors